Stay updated on Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Adds a new MedlinePlus Genetics topic on Head and neck squamous cell carcinoma and updates the page revision from v3.0.1 to v3.0.2, while removing the 'Back to Top' UI element.
    Difference
    0.5%
    Check dated 2025-09-14T21:52:56.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has been updated to version 3.0.1, and the section on head and neck squamous cell carcinoma has been removed.
    Difference
    0.5%
    Check dated 2025-09-07T18:48:07.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of various facility names and locations across multiple countries, as well as new resources related to genetic and rare diseases. Notably, several previously listed locations and terms have been removed.
    Difference
    12%
    Check dated 2025-08-31T12:26:05.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:41:09.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:32:23.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-01T18:53:50.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.